Review Recurring Topics

Time Windows of Interneuron Development: Implications to Our Understanding of the Aetiology and Treatment of Schizophrenia

  • Received: 01 September 2015 Accepted: 23 November 2015 Published: 28 November 2015
  • Schizophrenia is a devastating neuropsychiatric disorder widely believed to arise from defects during brain development. Indeed, dysfunction in the formation and function of GABAergic cortical interneurons has been implicated as a central pathogenic mechanism in this, and other, neurodevelopmental disorders. Understanding the coordination and timing of interneuron development including the complex processes of specification, proliferation, migration and their incorporation into finely tuned cortical networks is therefore essential in determining their role in neurodevelopmental disease. Studies using mouse models have highlighted the functional relevance of transcription factor networks and common signalling pathways in interneuron development but have faced challenges in identifying clear time windows where these factors are essential. Here we discuss recent developments highlighting critical time frames in the specification and migration of cortical interneurons and the impact of aberrant development to aetiology and treatments of schizophrenia.

    Citation: Zarina Greenberg, Hayley Ramshaw, Quenten Schwarz. Time Windows of Interneuron Development: Implications to Our Understanding of the Aetiology and Treatment of Schizophrenia[J]. AIMS Neuroscience, 2015, 2(4): 294-321. doi: 10.3934/Neuroscience.2015.4.294

    Related Papers:

    [1] Rozaziana Ahmad, Khairunnuur Fairuz Azman, Rosliza Yahaya, Nazlahshaniza Shafin, Norsuhana Omar, Asma Hayati Ahmad, Rahimah Zakaria, Adi Wijaya, Zahiruddin Othman . Brain-derived neurotrophic factor (BDNF) in schizophrenia research: a quantitative review and future directions. AIMS Neuroscience, 2023, 10(1): 5-32. doi: 10.3934/Neuroscience.2023002
    [2] Ian M Rowbotham, Franco F Orsucci, Mohamed F Mansour, Samuel R Chamberlain, Haroon Y Raja . Relevance of Brain-derived Neurotrophic Factor Levels in Schizophrenia: A Systematic Review and Meta-Analysis. AIMS Neuroscience, 2015, 2(4): 280-293. doi: 10.3934/Neuroscience.2015.4.280
    [3] Baptiste Lerosier, Gregory Simon, Sylvain Takerkart, Guillaume Auzias, Sonia Dollfus . Sulcal pits of the superior temporal sulcus in schizophrenia patients with auditory verbal hallucinations. AIMS Neuroscience, 2024, 11(1): 25-38. doi: 10.3934/Neuroscience.2024002
    [4] Ubaid Ansari, Vincent Chen, Romteen Sedighi, Burhaan Syed, Zohaer Muttalib, Khadija Ansari, Fatima Ansari, Denise Nadora, Daniel Razick, Forshing Lui . Role of the UNC13 family in human diseases: A literature review. AIMS Neuroscience, 2023, 10(4): 388-400. doi: 10.3934/Neuroscience.2023029
    [5] Fabrizio Turiaco, Fiammetta Iannuzzo, Giovanni Genovese, Clara Lombardo, Maria Catena Silvestri, Laura Celebre, Maria Rosaria Anna Muscatello, Antonio Bruno . Cognitive effects of brief and intensive neurofeedback treatment in schizophrenia: a single center pilot study. AIMS Neuroscience, 2024, 11(3): 341-351. doi: 10.3934/Neuroscience.2024021
    [6] Gianna Sepede, Francesco Gambi, Massimo Di Giannantonio . Insular Dysfunction in People at Risk for Psychotic Disorders. AIMS Neuroscience, 2015, 2(2): 66-70. doi: 10.3934/Neuroscience.2015.2.66
    [7] Ubaid Ansari, Jimmy Wen, Burhaan Syed, Dawnica Nadora, Romteen Sedighi, Denise Nadora, Vincent Chen, Forshing Lui . Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review. AIMS Neuroscience, 2024, 11(4): 505-519. doi: 10.3934/Neuroscience.2024031
    [8] Ziphozethu Ndlazi, Oualid Abboussi, Musa Mabandla, Willie Daniels . Memantine increases NMDA receptor level in the prefrontal cortex but fails to reverse apomorphine-induced conditioned place preference in rats. AIMS Neuroscience, 2018, 5(4): 211-220. doi: 10.3934/Neuroscience.2018.4.211
    [9] Graziella Orrù, Marina Baroni, Ciro Conversano, Angelo Gemignani . Exploring the therapeutic potential of tDCS, TMS and DBS in overcoming tobacco use disorder: an umbrella review. AIMS Neuroscience, 2024, 11(4): 449-467. doi: 10.3934/Neuroscience.2024027
    [10] Nicholas J. D. Wright . A review of the direct targets of the cannabinoids cannabidiol, Δ9-tetrahydrocannabinol, N-arachidonoylethanolamine and 2-arachidonoylglycerol. AIMS Neuroscience, 2024, 11(2): 144-165. doi: 10.3934/Neuroscience.2024009
  • Schizophrenia is a devastating neuropsychiatric disorder widely believed to arise from defects during brain development. Indeed, dysfunction in the formation and function of GABAergic cortical interneurons has been implicated as a central pathogenic mechanism in this, and other, neurodevelopmental disorders. Understanding the coordination and timing of interneuron development including the complex processes of specification, proliferation, migration and their incorporation into finely tuned cortical networks is therefore essential in determining their role in neurodevelopmental disease. Studies using mouse models have highlighted the functional relevance of transcription factor networks and common signalling pathways in interneuron development but have faced challenges in identifying clear time windows where these factors are essential. Here we discuss recent developments highlighting critical time frames in the specification and migration of cortical interneurons and the impact of aberrant development to aetiology and treatments of schizophrenia.



    1. Introduction

    The cerebral cortex is primarily comprised of two distinct neuronal populations namely excitatory neurons and GABAergic inhibitory interneurons which constitute approximately 80% and 20% of the neuronal population, respectively [1,2]. A fine balance between these two neuronal types is crucial for proper function of the complex brain networks. Dysfunction in GABAergic cortical interneurons has been implicated in several developmental disorders including schizophrenia, epilepsy, autism spectrum disorder and Down syndrome [3,4,5]. Now widely regarded as one of the main pathologies associated with schizophrenia, interneurons were brought to the forefront of research when post mortem schizophrenic brains were found to have decreased levels of GABA [6]. As discussed further below, numerous findings since then have also highlighted a subtype specific reduction in interneurons in the post mortem schizophrenic brain [7]and underpin the GABAergic/interneuron hypothesis of disease progression [8,9].

    The remarkable diversity of interneurons accounts for the complexity of the inhibition required for correct brain function; however, this complexity also makes the study of interneurons difficult and leaves many unanswered questions in the field. Interneurons differ from other locally derived cortical excitatory neurons in that they migrate large distances from their place of origin in the subpallium. To reach their target sites interneurons first undertake tangential migration into the neocortex and then switch to a radial migration phase to find their correct neocortical layer. In contrast, other neuronal cell types will undergo only a comparatively short migration along radial glial scaffolds to their target neocortical layer. This intricate migration combined with a complex specification process opens many avenues through which deficits can disrupt their development. The major hypothesis in schizophrenia, to date, suggests that its underlying pathology arises from defects during neuronal development (Reviewed in [10]). Indeed, more and more research implicates early developmental insult with irreversible dysfunction in adulthood as the likely mode of pathogenesis. If we are to understand the origins and identify rational treatment regimes for this disorder it is therefore essential to identify critical periods during embryonic and postnatal interneuron development.

    There are a wealth of studies addressing the specification and subsequent expression profiles of cortical interneurons as they migrate to the cortex, however, the field has lacked a clear understanding of the consequences of dysfunction at early development stages and their implications in the disease process. Understanding the coordination of interneuron specification, proliferation, migration, integration and specialisation is essential to determine their role in neurodevelopmental disease and provide insight toward novel therapeutic approaches. To date, studies have used mouse models to investigate the functional relevance of transcription factors and common signalling pathways in interneuron development but have not defined clear time windows where these molecules are critical. Here, we discuss recent developments in the study of the specification and migration of cortical interneurons and the impact of aberrant function during early developmental processes toward neuropsychiatric outcomes.

    2. Classification of Cortical Interneurons

    Different interneuron subpopulations show extraordinary diversity with distinct morphological, physiological and transcriptional profiles (see Figure 1) [11,12,13]. After initially being described over 100 years ago by Ramon y Cajal, interneurons were distinguished based on their morphology due to their short axons compared to excitatory neurons with little regard for their physiological properties [14]. There exists a large amount of inconsistency in classifying interneurons with some researchers referring to interneuron subclass based on morphology and cell type and others referring to their expression of marker proteins. Though their classification has been far from consistent over the last few decades, interneurons were traditionally sub-divided into three largely non overlapping groups based on their expression of calcium binding proteins Parvalbumin (PV), Calretinin (CR) and the neuropeptide Somatostatin (SST) [12,14,15]. Recently, however, this classification standard has changed with Lee and colleagues (2010) reporting that serotonin 5-hydroxytryptamine 3A receptor (5HT3aR) is expressed in the vast majority of interneurons that do not express PV or SST, therefore defining three major subtypes [16]. Each interneuron subtype has a unique function in controlling inhibition and excitation which is dependent on the position of the interneuron within the cortical circuit and its chemical profile. To control both inhibition and excitation of cortical networks interneurons regulate projection neurons in addition to other interneurons. It is important to consider that interneurons in each subtype have different morphology, intrinsic properties and can be further sub-divided into different classifications [17]. However, despite this, interneurons expressing similar markers will often have similar functions, origins and positions in the brain. PV expressing interneurons are mostly characterized as fast-spiking neurons essential for gamma oscillations, while SST+ interneurons have been established as low-threshold interneurons with SST+ Martinotti cells reported to fire at theta frequency [18], capable of sending low-threshold calcium spikes. Fast spiking interneurons have a unique function in feed forward inhibition in the brain due to their early response and hence expand the dynamic range of interneuron activity [19]. SST expressing interneurons in the fourth layer of the cortex act specifically in a disinhibiting context [20], this is contrasted by SST interneurons in layers 2/3 of the cortex whose primary function is to inhibit pyramidal neurons. Takada et al. 2014 reported that alterations to the distribution and/or subtype of interneurons leads to disorganized oscillation and lack of control [21]. Furthermore, many studies have suggested that the specific loss of PV interneurons without alterations to the total number of interneurons per se may be a primary factor in schizophrenia [7,22,23].

    Figure 1. Schematic illustration of the complex identity of interneurons. Cortical interneuron function can be classified based on their cell type, morphology, marker expression, origin and transcriptional profile. DB, Double bouquet; NGF, Neurogliaform; NPY, Neuropeptide Y; VIP, Vasointestinal peptide; CCK, Cholecystokinin; 5HT3aR,5-hydroxytryptamine 3a receptor.

    These largely non-overlapping subtypes can be further sub-divided on the basis of expressing additional interneuron markers with each having distinctive functional roles. Amongst these sub-divisions, the 5HT3aR expressing interneurons are particularly heterogeneous. For example, vasoactive intestinal polypeptide (VIP) is co-expressed in 40% of interneurons that express 5HT3aR with their primary function being the inhibition of other interneurons [17,24]. Reelin (RELN) is also co-expressed with the majority of 5HT3aR interneurons that do not express VIP. These RELN positive cells make up the majority of neuroglia interneurons in cortical layer I [17]. Unlike VIP and RELN, neuropeptide Y (NPY) is not only expressed in 5HT3aR but also in other interneuron types and is responsible for the slow GABAergic inhibition of pyramidal cells [24].

    3. Interneurons in other Regions of the Brain

    Interneurons are very diverse with populations found in all areas throughout the central nervous system, including the cortex, striatum, hippocampus, thalamus, cerebellum, hypothalamus, olfactory bulb and spinal cord. Interneurons in different areas have vastly different characteristics reflective of the area in which they are located. This is due to the neurochemical environment of each area of the brain as well as the function of the interneuron within the region. When studying the role of interneurons it is important to consider that within the different regions of the brain interneurons will arise from different proliferative zones and ultimately develop through different signalling and transcriptional mechanisms. Interneurons often have different morphologies between regions of the brain: interneurons of the striatum often appear projection-like which accounts for their need to function over large distances while cortical interneurons have short axon morphology and function within local circuits. Furthermore, the interneuron marker expressed by certain cell types is also dependent on the area of the brain. For example, in the hippocampus SST is expressed in Oriens Lacunosum-Moleculare cells however in cortical interneurons SST is predominately expressed in Martinotti cells.

    4. Generation of Cortical Interneurons

    Cortical interneurons are born in the ganglionic eminences and the Preoptic Area (PoA) in the ventral telencephalon of the developing rodent brain. These ganglionic eminences can be subdivided into various regions depending on their physical location, including the Lateral Ganglionic Eminence (LGE), Medial Ganglionic Eminence (MGE) and Caudal Ganglionic Eminence (CGE) (See Figure 2). The area in which an interneuron is born plays an important role in dictating the fate and function of that interneuron. For example, an interneuron born in the MGE will incur an MGE-like fate and likely give rise to a PV or SST phenotype. Interneurons born in the CGE will likely express 5HT3aR and have a different transcriptional profile than MGE derived interneurons. Though the LGE has been associated with some interneuron populations (i.e. olfactory bulb and striatal interneurons), it has not been found to produce any cortical interneuron populations in mice. Indeed, most fate mapping studies in mice suggest that the vast majority (approximately 70%) of cortical interneurons derived from the MGE [25].

    Figure 2. Schematic illustration of the Ventral Telencephalon region in the developing mouse brain. Interneurons are born in the ganglionic eminences in the ventral telencephalon of the developing rodent brain, specifically the medial (MGE), lateral (LGE) and Caudal (CGE), and to a lesser extent the Preoptic Area (PoA). Shh and Wnt signalling are important pathways in the development of interneurons and are expressed in high to low gradients throughout the developing brain. This gradient is important in establishing different classes of interneurons from different ganglionic regions.

    The Sonic Hedgehog (Shh) signalling pathway has been identified as a key factor in interneuron specification and development. In the rodent brain, the morphogen Shh is secreted from the floor plate of the neural tube along the entire rostral/caudal axis between embryonic day E8.5-E9.0. This initial expression later induces Shh expression in the PoA region and mantle zone of the MGE, where post-mitotic MGE neurons are located [26,27,28]. Though reduced, Shh will continue to be expressed throughout development and in some cell types even into adulthood [27]. The most well characterized Shh signalling pathway is mediated via a Gli dependent mechanism in which Shh binds to the inhibitory cell surface receptor Patched to release another cell surface receptor Smoothened from a state of inhibition. Disinhibition of Smoothened then leads to activation of the Gli transcription factors that relocate to the nucleus. Within the MGE, activation of Gli family proteins leads to the up regulation and maintenance of the early NK homeobox transcription factor Nkx2.1, as well as providing positive feedback to maintain expression of Shh itself [27,29].

    5. Sonic Hedgehog Signalling Induces Cortical Interneuron Formation

    Despite Shh signalling being generally well characterized elsewhere during embryogenesis, its expression and function within the ganglionic eminences is complicated, and to date, incompletely understood. Shh signalling has a critical role in the initial patterning of the ganglionic eminences, as highlighted in the FoxG1-Cre:Smoothenedfl/fl line where Smoothened is deficient from the telencephalic neural precursor population from E9.5 [30]. In these mice the ganglionic eminences fail to undergo initial expansion and patterning, emphasizing a critical role of Shh in the development of all cortical interneurons. A reduction in Shh after the formation of the ganglionic eminences at E12.5 has also been documented to lead to a reduction in the SST+ and PV+ expressing interneurons [31,32,33]. However, in this case the altered interneuron landscape occurs without affecting the total number of interneurons in the cell cycle (S-phase), and with only minimal effect on CGE derived interneurons [33]. These findings correspond well with the expression gradient of Shh along the rostral/caudal axis and within the PoA and MGE. Interestingly, Xu et al. 2010 showed that overexpression of Shh in the MGE resulted in low-threshold SST subtype interneurons being favoured at the expense of fast spiking PV+ cells [34]. This is fitting with the data since the SST population of interneurons predominantly arise from cells located more rostrally than those giving rise to PV+ interneurons. These findings suggest that although some cell types are favoured with either an increase or decrease of Shh expression, that Shh signalling is crucial for all interneuron subtypes and that a delicate balance of Shh activity is essential for proper interneuron development and cell identity. This data therefore identifies 3 core roles for Shh in interneuron development: (1) contribution to initial patterning and specification of the ganglionic eminences in early development (E9-E12.5), (2) expansion of progenitors in the ventral telencephalon (E12.5), and (3) maintaining expression of Nkx2.1 within the MGE (E12.5 onwards) [34].

    At the earliest stages of interneuron specification, Shh initiates a signalling cascade that leads to the up regulation of Gli1 and Gli3 transcripts, which further lead to expression of the transcription factor Nkx2.1 within the MGE and PoA. The role of Nkx2.1 in the MGE has been previously well described [35], here we will briefly discuss more recent findings. The expression of Nkx2.1 is crucial at an early time point to generate a downstream transcriptional response which leads to the specification of different interneuron subclasses. As the loss of Nkx2.1 results in no changes to CGE derived interneurons this further suggests that Nkx2.1 is preferentially required by the MGE and the PoA [33]. Sox6 and Lhx6 act downstream of Nkx2.1 and have a key role in the differentiation and migration of MGE derived interneurons. In Sox6 knockout mice MGE derived neurons are mispositioned and fail to express PV and SST correctly [36]. Interestingly, while this altered expression profile and mispositioning phenotype is also observed in Lhx6 knockout mice, the MGE derived cells are pushed toward a CGE like cell fate in these mice. Given the dual defects on interneuron positioning and specification, this raises the question of whether the role of specification has downstream effects on migration or whether Lhx6 acts upon multiple developmental processes independently. After initially deriving from the floor plate and the PoA, Shh expression is later driven in the MGE by Nkx2.1 and the Lhx transcription factor family via a positive feedback loop. While Lhx6 and its homolog Lhx8 have largely redundant functions in regulating interneuron development, when removed together, Lhx6;Lhx8 double knockout mice lack Shh expression in early MGE derived neurons (E11.5) [27].

    Despite its initial role acting under the Gli-dependent pathway, Shh has also been found to have Gli-independent actions in maintaining Nkx2.1 expression at later developmental stages (i.e. after E12.5). Gulacsi and Anderson (2006) found that removal of Shh in a Gli3 null background was necessary to inhibit Nkx2.1 expression. While the initial patterning of the MGE relies on the Gli dependent pathway, progenitor expansion and patterning maintenance also require a Gli independent pathway [35]. Furthermore, Shh’s role in maintaining Nkx2.1 expression in the absence of Gli may be indirect. Gulacsi & Anderson (2006) put forward the hypothesis that Shh may regulate Nkx2.1 in the absence of Gli by repressing the inhibitory effect of Wnt or BMP. To date there is little research looking into the effects of Shh in maintaining Nkx.2.1 in a Gli independent manner. It will be important for the field to determine the significance of this interaction and how this could be potentially impacting on neurodevelopmental disorders.

    Despite numerous advances in our understanding of the complex relationship between transcription factor networks and interneuron fate, the transcription profiles of interneuron subtypes and the consequences of abnormal specification are poorly understood. Unfortunately due to the redundant nature of these transcription factors and lack of knowledge of their roles at variable time points of interneuron development it is difficult to gauge the true effect of an abnormal transcription profile in the formation of physiological traits associated with schizophrenia.

    6. Additional Signalling Pathways Involved in Cortical Interneuron Development

    Although Shh arguably plays the most important role in patterning the ganglionic eminences, the Wnt, FGF and BMP signalling pathways have also been implicated in coordinating cortical interneuron development. In many cases these signalling pathways interact in a reciprocal manner, with the activation of one pathway inhibiting the activity of the other [37]. For example, the bone morphogenetic protein (BMP) family represses the expression of Shh via a negative feedback loop in tissues outside the brain [38] and represses Shh induced interneuron production in cortical explants [39]. BMPs also play essential roles in refining the expression patterns of Shh within the ventral midline prior to induction of Nkx2.1 in the ganglionic eminences [40]. After initial specification within the MGE interneurons migrate into the cortical layers. Upon reaching the cortex BMPs also play important roles in interneuron subtype specification [41,42,43]. Indeed, while mice lacking the BMP receptors BMPR1a and BMPR1b have a similar degree of GABAergic neurons overall, they have reduced PV+ expressing interneurons compared to controls.

    Fibroblast growth factor (FGF) signalling is also essential for expansion and patterning of the MGE, with most evidence suggesting that FGFs act as effectors of Shh signalling. In the absence of FGF receptors (i.e. Fgfr1; Fgfr2 double knockout mice) the MGE fails to express Nkx2.1 albeit that Shh and Gli1 expression is normal [44]. This morphogenic cascade is further supported by the finding that Fgf8 expression is dysregulated in both Gli3 and Shh knockout mice [38,45].

    Wnt signalling pathways are conventionally categorized as either canonical or non-canonical depending on whether β-catenin is the primary target of the cascade. In canonical Wnt signalling, activation of Wnt ligands stabilizes cytoplasmic β-catenin which would otherwise be degraded by GSK3β. This stabilization leads to a build-up of β-catenin in the cytoplasm and initiates its transportation to the nucleus where it interacts with transcriptional co-regulators to promote target gene expression. Wnt signalling has well defined roles in promoting neuronal identity, proliferation and migration [46,47,48,49] and has been shown to negatively regulate cell fate and neuronal identity in the subpallium [50]. More recently, canonical Wnt signalling has been shown to directly mediate interneuron cell cycle progression. Using Nkx2.1Cre; β-catfl/fl mice and a range of ex vivo assays in which the Wnt signalling pathway has been modulated, Gulacsi & Anderson (2008) found that loss of canonical Wnt signalling lead to proliferation defects within the MGE [51]. The Wnt/β-catenin pathway has also been shown to promote expression of the transcription factor Sox5 to control interneuron proliferation within the spinal cord [52]. However, whether this molecular pathway is also at play in the subpallium remains to be explored. Recent findings in the olfactory bulb have also shown that non-canonical Wnt signalling is important for interneuron development in other regions of the brain. Pino et al. (2011) identified a role for Wnt5a (associated with non-canonical Wnt signalling) but not Wnt3a (associated with canonical Wnt signalling) in neurite formation and morphology of olfactory bulb interneurons in vitro [53]. While the role for non-canonical Wnt signalling in cortical interneuron development remains undefined the field would benefit immensely from detailed analysis of receptors specific to this pathway. Indeed, modulation of receptors specific to the canonical pathway would also be helpful in determining which defects arising from β-catenin deficiency are specific to Wnt signalling.

    Though the signalling pathways described above are known to interact with one another, the exact mechanisms and significance of these interactions are incompletely understood. To date, most investigations have studied these pathways independently, which may give an incomplete understanding of how these complex signalling pathways interact.

    7. Tangential Migration of Cortical Interneurons

    Interneurons begin migration from the ganglionic eminences at approximately E11.5 in response to chemoattractant and chemorepellent cues from the cortex and striatum. This migration will continue throughout embryonic development until the formation of new neurons within the ganglionic eminences has ceased. Unlike other neuronal cell types, interneurons exit the cell cycle before migration, with Lhx6 being expressed after undergoing cell cycle exit. Failure to exit the cell cycle before migration results in aberrant migration and ectopic positioning of postnatal interneurons within the cortex. For example, Vidaki and colleagues (2012) showed that a reduction of Rac-1 in progenitor interneurons perturbed G1 cell-cycle progression thus resulting in a subsequent loss of MGE derived interneurons in the cortex [54]. However, reduction of Rac-1 after the onset of interneuron migration had no effect on the cell cycle and showed little to no effect on the interneuron landscape in older mice.

    To reach their appropriate position within the cortex interneurons must first navigate away from the ganglionic eminences and into the dorsal pallium. Invasion of the cortex is highly ordered and occurs through two major tangential migration pathways. The first neurons to exit the ganglionic eminences are primarily biased toward PV+ fate and migrate around the striatum and into the Marginal Zone (MZ). In contrast, the neurons born at later time-points consist of a mixed population of interneurons that migrate through the subventricular zone (SVZ) (see Figure 3A). The first stage of migration out of the ganglionic eminences is primarily controlled by chemorepulsion signals that were originally described as axonal guidance cues. The class 3-semaphorins (Sema3A and Sema3F) are expressed by the striatum and interact with the cell surface neuropilin receptors (NRP1 and NRP2) which are expressed on migrating interneurons. Due to the presence of chemorepulsive signals interneurons expressing the neuropilin receptors migrate around the striatum in a distinctive path. Indeed, deficiency of the neuropilin receptors leads to aberrant interneuron migration with an increase number of interneurons localising to the striatum [55]. Notably, the interneurons that target the striatum during normal developmental contexts lack expression of the neuropilin receptors [56]. This semaphorin/neuropilin axis therefore represents part of the mechanism for sorting different classes of interneurons to their appropriate locations, similar to their roles in other neuronal types [57,58,59]. Hernández-Miranda et al. (2011) showed that the roundabout 1 receptor (Robo1) is also important for guiding newly formed interneurons out of the ganglionic eminences and along the tangential migration paths [60]. Robo1 is a transmembrane receptor that recognises secreted chemorepulsive signals from the Slit family. Robo1 is expressed by migrating interneurons within the ganglionic eminences and the Slit ligands are expressed in complementary pattern within the ventricular zone of the cortex [61]. However, rather than controlling migration along the tangential paths in the cortex, the Slit/Robo signalling pathway also helps to keep interneurons away from the striatum [55,60]. The overlap in phenotypes of the Slit/Robo and semaphorin/neuropilin knockout mice may be partly explained by the finding that Robo1 can physically interact with neuropilin [60], perhaps suggesting that the two pathways functionally interact. The Eph/Ephrin signalling pathway also plays important roles in promoting the initial phases of interneuron migrations away from the ganglionic eminences. EphrinB3 and EphA4 are reciprocally expressed in MGE and POA derived interneurons and through forward/reverse signalling are involved in sorting these different classes toward different cortical migratory streams [62]. EphrinA5 is also expressed in the ventricular zone of the MGE and interactions between EphrinA5 and EphA4R are required to push interneurons away from the ventricular zone [63]. The aristaless related homeobox transcription factor ARX has also been suggested to have an important role in promoting early interneuron migration. ARX knockout mice display an aberrant accumulation of interneurons in the proliferative zones of both the MGE and the CGE which results in the loss of cortical interneurons at later stages [64]. However, as interneuron progenitors fail to exit the cell cycle in ARX deficient mice, its role in migration as opposed to specification is unclear.

    Figure 3. Migration of cortical interneurons. (A) Cortical interneurons born in the ganglionic eminences will migrate via two spatially distinct pathways to the neocortex. Early migrating cells will migrate from the MGE and into the marginal zone (MZ) and later migrating cells will migrate via the subventricular zone (SVZ). Repulsive cues, specifically Sema3A and Sema3F, are expressed in the striatum to aid in directing cortical migration away from the striatum and towards the neocortex. Nrg-1 also acts as a morphogenic factor to direct migration to the neocortex. (B) Interneurons switch from tangential migration to radial migration once they reach the neocortex. Radial migration will allow interneurons to distribute throughout the cortex into their ultimate laminar position. Early migrating interneurons will occupy the deeper layers of the cortex whereas later migrating interneurons will occupy the more superficial layers.

    Cortical interneurons that navigate around the striatum to enter the pallium then migrate further dorsally under control of chemoattractive cues. The epidermal growth factor family member neuregulin-1 (Nrg-1) is expressed in the cortex and has been suggested to act as an attraction signal for interneurons expressing the tyrosine kinase family receptor ErbB4 [65]. However, the exact role of neuregulins in interneuron development is still open to debate. Contrary to the notion that neuregulins act as chemoattractive cues, data recently reported by Li et al. (2012) suggest that neuregulin may instead act to inhibit the tangential migration of interneurons [66]. In the latter example the authors found minimal overlap between interneurons and neuregulin expression domains in wild-type mice but found significant colocalisation of interneurons in these expression domains in ErbB4 knockout mice. The chemokine receptors CXCR4 and CXCR7, which interact with the secreted ligand SDF-1, have also been found to have a role in tangential migration within the cortex [67]. Thus, in CXCR4 and CXCR7 knockout mice there is a 25% reduction in Lhx6 expressing interneurons in the lateral regions of the neocortex [68].

    8. Radial Migration and Laminar Distribution of the Interneurons in the Cortex

    Once interneurons reach the developing neocortex, they change from long distance tangential migration to radial migration before settling in their final resting place where they integrate into local cortical circuits. Interneurons sort into deep and superficial layers in an inside out fashion with the first-born MGE derived interneurons occupying the deeper layers and later CGE derived interneurons occupying more superficial layers (see Figure 3B). There is a large amount of evidence to suggest that the final position of interneurons is dictated at their time of birth and that interneurons will ultimately localise to the same cortical layer as projection neurons born at the same time. While the mechanisms controlling this colocalisation remain unknown it has been suggested that interneuron radial migration may be arrested in response to interactions with projection neurons born on the same day in neurogenesis [69].

    Correct distribution of interneurons throughout the cortical layers is essential for their ultimate function and the formation of cortical microcircuits. In comparison to the well-described migration route of pyramidal neurons along radial glial scaffolds interneurons have been found to migrate independently of glia and in response to different molecular cues [70,71,72]. While SDF-1 is a positive regulator of tangential migration within the cortex, its down regulation may also play an important role in promoting the switch to radial interneuron migration at later stages of development. Thus, the inhibition of SDF-1/CXCR signalling in slice cultures after interneurons have already navigated into the cortex promoted a rapid switch from tangential to radial migration [73]. Defects in radial migration have also been shown in Lhx6 deficient mice. In these mice interneurons failed to occupy the middle neocortex, and instead occupy the very deep or superficial layers [74,75]. Interestingly, this deficiency was somewhat reversed by the addition of downstream proteins CXCR7 and ARX at E13.5, identifying this as a critical period for interneuron radial migration.

    9. The GABAergic/Interneuron Hypothesis of Schizophrenia

    Although the aetiology of schizophrenia is not well understood, there is general consensus within the field that disrupted connectivity is a central component in its pathology [76]. Recent studies have shown that neuronal migration, neurite formation and disruption of synapses are key influences in the formation of clinical symptoms [77,78]. These findings provide strong support to the notion that the pathophysiology may be due to underlying disturbances in brain formation. Indeed, further support of a neurodevelopmental origin has come from the absence of neurodegenerative defects in post-mortem schizophrenia brain samples [79].

    The link between interneuron deficiency and schizophrenia was first established in the 1970’s by Perry and colleagues [6] who reported a loss of the inhibitory neurotransmitter GABA in post mortem brain samples. In the 40 years since this first description, cortical interneuron defects have been consistently found in post-mortem tissue samples of schizophrenia patients. At the structural level, a common finding has been aberrant interneuron density and altered cellular distribution within multiple brain areas including the cingulate cortex [80], hippocampus [81,82], orbital cortex [83], prefrontal cortex [84,85,86,87], fusiform cortex [88] and planum temporale [89]. However, while altered positioning of neurons within the adult schizophrenic brain has been taken to reflect earlier defects in neuronal migration, whether these anatomical defects arise from aberrant developmental processes has been hard to ascertain due to an inability to analyse brain structure in the prodromal stage of the disease.

    Altered expression of genes involved in interneuron development and function are also correlated with clinical symptoms. Several molecules within the GABA signalling pathway including the enzymes responsible for synthesising GABA, GAD67 and GAD65 (encoded by the genes GAD1 and GAD2, respectively), and the GABA transporter, GAT1, are often deficient in schizophrenia brain samples [7,23,90,100]. The GABA receptor subunits GABRA1-2, GABRA4-6, and GABRD that are present on excitatory neurons and responsible for post synaptic neurotransmission are also reported to be aberrantly expressed in several schizophrenia studies [80,101,102,103,104]. Contrary to expectation, however, in some cases the expression of GABA receptors is increased, which may arise as a compensatory mechanism for reduced interneuron density or aberrant function [80,100,105,106,107,108]. An increase in expression has also been noted for ErbB4 and its ligand Nrg-1 [105,106,107,108]. Perhaps the strongest evidence of an interneuron deficiency playing a role in disease progression comes from deficient expression of interneuron markers such as PV, SOM, NPY, CB, RELN and cholecystokinin (CCK) [7,102,103,104,109,110,111,112]. Moreover, many of these studies also report a subtype specific reduction of interneuron markers in schizophrenia patients compared to controls [112].

    At the genetic level, Straub and colleagues (2007) have shown that a single-nucleotide polymorphism (SNP) haplotype within the promoter region of GAD1 correlates well with reduced gene expression in several schizophrenia-based families [113]. The down regulation of GAD1 and the 5HT3aR interneuron marker RELN have also been shown to occur as a response to epigenetic changes in their promoter elements [114,115,116,117,118,119]. The Nrg-1 locus has strong linkage with schizophrenia with various non-coding polymorphisms and haplotypes identified within and around the promoter region of the gene [106]. Although not discussed in detail here, brain derived neurotrophic factor (BDNF) plays important roles in interneuron development and establishing cortical circuits during adolescence [120,121]. Notably, a Val66Met coding variant in BDNF has been associated with psychiatric disorders and reduced cortical and hippocampal volumes in a number of studies [122,123]. Recent whole exome sequencing and Genome Wide Association Studies (GWAS) on large schizophrenia cohorts further strengthen the genetic link between interneuron deficiency and disease pathogenesis. For example, from the analysis of 623 schizophrenia trios Fromer et al. (2014) revealed missense mutations in several genes known to play critical roles in interneuron development, including Lhx6, Gli2, Gli3 and ErbB2 [124]. Moreover, GWAS studies have found linkage to genes and molecular pathways involved in interneuron development, including Nrg-1, ErbB4 and genes within the Wnt signalling pathway [125,126]. The overall outcome of these genome wide studies is the realisation that although schizophrenia has a large genetic component, no single gene defect can explain the origin of the disease. Rather, the most likely explanation of clinical onset is synergistic effects of genetic and environmental insults acting on similar molecular pathways during critical stages of brain development.

    With growing evidence of the GABAergic/Interneuron hypothesis, many questions are raised in regard to the contribution of interneuron deficiencies with dysfunctions in the glutamatergic and dopaminergic neurotransmitter pathways that have been identified in patient cohorts. Direct interplay between the GABAergic and hypoglutamatergic hypotheses has been addressed in mice by the specific removal of N-methyl-D-aspartic acid receptors (NMDAR) in GABAergic interneurons [127]. In strong support of interneuron deficiencies aligning with the glutamatergic dysfunction these mice presented with molecular, behavioural and physiological defects akin to those seen in the human condition [127]. Direct interactions between aberrant cortical inhibition and dopamine signalling have also been proposed, however, how this link is functionally established is highly debated. For a detailed account of the possible interactions between GABAergic deficiency and the hyperdopaminergic basis of schizophrenia we refer readers to a recent review dedicated to this topic [8]. One possible link is cortical disinihibition leading to increased dopamine in the nucleus accumbens as found when NMDAR antagonists were infused in to the prefrontal cortex of mice [128]. Considering the role of interneurons in modulating many neuronal networks it is likely that deficiency of interneurons during development may also contribute to the decreased glutamatergic and increased dopaminergic basis of disease progression.

    10. Mouse Models of Schizophrenia

    In order to understand the neurobiological basis and the causal relationship between interneuron deficiency and disease pathogenesis several mouse models of schizophrenia risk factors have been developed. Despite the genetic heterogeneity of the disorder, many of these mouse models have demonstrated interneuropathies (reviewed in [129]) and behavioural phenotypes representing the human condition. GAD67 knockout mice are perinatal lethal but removal of this gene in specific populations of interneurons during postnatal and embryonic stages of development has been shown to induce behavioural and anatomical defects reminiscent to those in schizophrenia [9,130,131]. Moreover, behavioural changes as a result of amphetamine dosage further suggest that mice lacking GAD67 in interneurons have altered dopaminergic signalling and therefore provide a direct link between the two neurotransmitter systems [131]. As GAD67 is essential for synthesis of GABA, removal of this enzyme in adult mice also leads to schizophrenia-like molecular and behavioural dysfunctions [131,132]. Taken together, these studies further suggest that the deficiency of GAD67 identified in human cohorts is likely to contribute to at least part of schizophrenia behavioural deficits.

    Complete removal of ErbB4 in mice leads to a 30% reduction of PV-positive interneurons and a corresponding decrease in gamma oscillations that are essential for brain connectivity [133]. Consistent with a cell autonomous role, removal of ErbB4 specifically from fast spiking interneurons also lead to cortical excitability, disruption of gamma oscillations and schizophrenia-like behavioural deficits [134].

    One of the most replicated risk factors for schizophrenia is disrupted in Schizophrenia 1 (DISC1) that was first identified in a large Scottish family who had a breakpoint in this gene that occurred through a balanced chromosomal translocation [135]. To recapitulate this mutation several mouse models have been generated to either remove or knock down the DISC1 gene in a cell type specific manner. Notably, removal of DISC1 from MGE at E13.5 has been shown to lead to a loss of cortical interneurons in adult mice that arises from aberrant tangential migration. How DISC1 modulates interneuron migration and whether this defect replicates the schizophrenia-like behavioural defects of DISC1 knockout mice remains to be explored [136].

    Interneuron deficiencies and dysfunction have also been reported in many of the well-described environmentally induced mouse models of schizophrenia. The gestational MAM model in which the anti-mitotic and anti-proliferative agent MAM is administered to gestational day 17 rats recapitulates many of the anatomical, behavioural and processing defects observed in schizophrenia [137]. The MAM model leads to a specific loss in PV+ interneurons in the cortex which results in a loss of function in oscillation activation [138] and has also been linked to hyperactivity of ventral tegmental dopaminergic neurons [139]. Prenatal maternal immune activation (MIA) has been implicated as a risk factor for schizophrenia and MIA induced in rodents at various gestational ages precipitates behavioural, cognitive and pharmacological abnormalities in late adolescence [140,141]. MIA in rodents leads to GABAergic dysfunction similar to that defined in humans, with decreased GABA, decreased GAD1 and increased levels of GABA receptor subunits [141,142,143,144,145]. The MIA models have also been used to address gene and environmental interactions in schizophrenia pathophysiology. In DISC1 mutant mice that have no behavioural abnormalities the sub-clinical application of the MIA agent poly (I:C) leads to the manifestation of schizophrenia-like phenotypes [146,147]. Stress is also a reported risk factor for schizophrenia and chronic stress induced postnatally in rats leads to altered brain development and behavioural deficits in late adolescence [148]. Rodent pups isolated from the age of weaning have reduced PV and calbindin immunoreactive neurons in the hippocampus and prefrontal cortex [149,150]. In addition, RELN expression was also decreased in the prefrontal cortex of rats raised in isolation with the peak stage of deficiency correlating with the onset of behavioural defects [151]. Stress has also been shown to synergise with MIA to induce schizophrenia-like deficiencies [152]. In mice with sub-clinical doses of poly (I:C) during gestation, peripubertal stress also leads to reduced GAD67 in several brain regions [143].

    Earlier in this review we discussed several mouse models that provide insight to the molecular mechanisms controlling interneuron development. Many of these models have also been used to model schizophrenia. For example, GAD67, Nrg-1 and ErbB4 are known susceptibility genes for schizophrenia [126,153,154,155] and mouse models removing these genes have been explored widely. Notably, many of these studies not only highlight the critical roles of these genes in interneuron development but also in interneuron function. Deficiency of Shh and Nkx2.1 in the MGE clearly lead to interneuron defects. However, given the lethality of mice lacking these genes their roles in behaviours associated with the human condition have been harder to address [156,157].

    11. Implications of Cortical Interneurons in the Aetiology and Treatment of Schizophrenia

    This review has so far highlighted the importance of critical time periods during embryonic interneuron development. In this section we now discuss the correlation of these critical times with human cortical development and the translational relevance of this understanding toward innovative and improved therapeutics in schizophrenia. It is widely accepted that schizophrenia is likely to arise from genetic and environmental insults during embryonic and post-natal development. Whether schizophrenia, which has an average age of onset between 16-25 years [158], could arise from aberrant interneuron development therefore stands as an important question. The specification and migration of interneurons, as discussed earlier, is largely completed in the early postnatal period. However, the final maturation of cortical networks is only achieved much later in adolescence. In humans the brain reaches maturation in the early 20’s and this is recapitulated in mice where interneurons continue to mature up until the end of adolescence [159,160]. During adolescence the brain undergoes a period of rapid synaptic pruning and cortical thinning [159,161,162] which coincides with a time of strong emotional states and increased stress [159,160]. These cortical rearrangements extend the period of interneuron development from early embryogenesis through until late adolescence and define a large time window in which environmental insults can also occur. This protracted developmental period is also likely to account for the late manifestation of behavioural deficits in early adulthood.

    As the diagnosis of schizophrenia is only made after the time window of interneuron development has closed, this poses a particular challenge for therapeutic methods targeted at replacing or fixing interneuron deficiency. The identification of early diagnostic markers and predictive testing is therefore essential if we are to provide innovative opportunities to alter the disease course during the critical time window. Nonetheless, it may also be possible to reopen artificial time windows as discussed below. Although it was once thought that neurogenesis ceases at birth, it is now well accepted that the adult brain contains a limited number neural stem cell progenitors that provide a population of renewable neurons throughout life. Pharmacological manipulation to enhance neurogenesis in the brain is not a new concept, however, has to date not been explored in the context of schizophrenia [163,164]. Although speculative, the notion of expanding the population of interneurons from resident neural stem cells could be perceived as one way of opening an artificial time window in adulthood. To achieve such a feat it would be necessary to reinstate a similar signalling environment as that experienced in the embryonic ganglionic eminences within the adult brain. Another possible means of therapy may be derived from increasing connectivity or functionality of the remaining interneuron populations within the schizophrenic brain. This could perhaps be achieved by increasing the number of functional synapses or via the up regulation of genes controlling interneuron function. In the latter case, demethylation agents such as histone deacetylase (HDAC) inhibitors may be of use in restoring gene function in cases where epigenetics are at play [118,119,165]. Indeed, support of such an approach may be taken from the use of the atypical antipsychotic drug clozapine that, in addition to its other affects, has recently been shown to induce DNA demethylation [165].

    Interneuron transplantation may also be seen as another method of overcoming the challenges faced by a closed developmental time window. Taking advantage of the unique ability of immature interneurons to undergo long distance tangential migration, interneuron transplantation into the adult striatum, cortex and hippocampus has been gainfully exploited to replace interneurons in animal models. Initially described by Wichterle and colleagues (1999), interneurons were derived from embryonic MGE and injected into adult mice [166]. Remarkably, interneurons were able to migrate through the adult cortex and disperse into the appropriate layers. One of the earliest examples of interneuron transplantation was in the MAM model of schizophrenia, in which MAM treated rats were injected with MGE derived cells. After migrating to the cortex these cells were able to differentiate and form functional synapses with existing pyramidal neurons to rescue deficits in GABAergic signalling. Furthermore, this also rescued aberrant dopamine signalling associated with these mice [167]. This technique has since been performed on several mouse models of psychosis and other neurodevelopmental disorders (reviewed in [168]) and provides hope of a cellular based therapy for neuropsychiatric disorders. This exciting method thereby introduces a new window of plasticity into the otherwise developed brain and may potentially be harnessed for the long-term treatment of interneuron deficiency in schizophrenia.

    12. Conclusion and Summary

    The loss of interneurons in the adult brain has been implicated in several developmental disorders with a clear link to psychosis. Due to their complex developmental progression, loss of interneurons or interneuron dysfunction can result from insults to many molecular pathways at almost any stage of brain development. Understanding critical stages at which different molecular pathways are required during development and the outcomes of insults at differing time points are imperative in understanding the roles of interneurons in neurodevelopmental disorders and psychiatric illness. Such information is likely to provide insight toward innovative therapies and preventative medicines for this highly prevalent disorder.

    Conflict of Interest

    The authors do not have any conflict of interest to disclose.

    [1] Hendry SH, Schwark HD, Jones EG, et al. (1987) Numbers and proportions of GABA-immunoreactive neurons in different areas of monkey cerebral cortex. J Neurosci 7: 1503-1519.
    [2] Meinecke DL, Peters A (1987) GABA immunoreactive neurons in rat visual cortex. J Comp Neurol 261: 388-404. doi: 10.1002/cne.902610305
    [3] Levitt P, Eagleson KL, Powell EM (2004) Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci 27: 400-406. doi: 10.1016/j.tins.2004.05.008
    [4] Lewis DA (2000) GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res Brain Res Rev 31: 270-276. doi: 10.1016/S0165-0173(99)00042-9
    [5] Rubenstein JL, Merzenich MM (2003) Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2: 255-267. doi: 10.1034/j.1601-183X.2003.00037.x
    [6] Perry TL, Kish SJ, Buchanan J, et al. (1979) Gamma-aminobutyric-acid deficiency in brain of schizophrenic patients. Lancet 1: 237-239.
    [7] Hashimoto T, Volk DW, Eggan SM, et al. (2003) Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23:
    6315-6326.
    [8] Nakazawa K, Zsiros V, Jiang Z, et al. (2012) GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology 62: 1574-1583. doi: 10.1016/j.neuropharm.2011.01.022
    [9] Schmidt MJ, Mirnics K (2015) Neurodevelopment, GABA system dysfunction, and schizophrenia. Neuropsychopharmacology 40: 190-206. doi: 10.1038/npp.2014.95
    [10] Gupta S, Kulhara P (2010) What is schizophrenia: A neurodevelopmental or neurodegenerative disorder or a combination of both? A critical analysis. Indian J Psychiatry 52: 21-27. doi: 10.4103/0019-5545.58891
    [11] DeFelipe J (2002) Cortical interneurons: from Cajal to 2001. Prog Brain Res 136: 215-238. doi: 10.1016/S0079-6123(02)36019-9
    [12] Gonchar Y, Burkhalter A (1997) Three distinct families of GABAergic neurons in rat visual cortex. Cereb Cortex 7: 347-358. doi: 10.1093/cercor/7.4.347
    [13] Kawaguchi Y, Kubota Y (1997) GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb Cortex 7: 476-486. doi: 10.1093/cercor/7.6.476
    [14] DeFelipe J, López-Cruz PL, Benavides-Piccione R, et al. (2013) New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci 14:
    202-216.
    [15] Petilla Interneuron Nomenclature G, Ascoli GA, Alonso-Nanclares L, et al. (2008) Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat Rev Neurosci 9: 557-568. doi: 10.1038/nrn2402
    [16] Lee S, Hjerling-Leffler J, Zagha E, et al. (2010) The largest group of superficial neocortical GABAergic interneurons expresses ionotropic serotonin receptors. J Neurosci 30: 16796-16808. doi: 10.1523/JNEUROSCI.1869-10.2010
    [17] Rudy B, Fishell G, Lee S, et al. (2011) Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons. Dev Neurobiol 71: 45-61.
    [18] Fanselow EE, Richardson KA, Connors BW (2008) Selective, state-dependent activation of somatostatin-expressing inhibitory interneurons in mouse neocortex. J Neurophysiol 100:
    2640-2652.
    [19] Hu H, Gan J, Jonas P (2014) Interneurons. Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function. Science 345: 1255263.
    [20] Xu H, Jeong HY, Tremblay R, et al. (2013) Neocortical somatostatin-expressing GABAergic interneurons disinhibit the thalamorecipient layer 4. Neuron 77: 155-167. doi: 10.1016/j.neuron.2012.11.004
    [21] Takada N, Pi HJ, Sousa VH, et al. (2014) A developmental cell-type switch in cortical interneurons leads to a selective defect in cortical oscillations. Nat Commun 5: 5333. doi: 10.1038/ncomms6333
    [22] Fung SJ, Webster MJ, Sivagnanasundaram S, et al. (2010) Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. Am J Psychiatry 167: 1479-1488. doi: 10.1176/appi.ajp.2010.09060784
    [23] Volk DW, Austin MC, Pierri JN, et al. (2000) Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57: 237-245. doi: 10.1001/archpsyc.57.3.237
    [24] Vitalis T, Rossier J (2011) New insights into cortical interneurons development and classification: contribution of developmental studies. Dev Neurobiol 71: 34-44. doi: 10.1002/dneu.20810
    [25] Peyre E, Silva CG, Nguyen L (2015) Crosstalk between intracellular and extracellular signals regulating interneuron production, migration and integration into the cortex. Front Cell Neurosci 9: 129.
    [26] Ericson J, Muhr J, Placzek M, et al. (1995) Sonic hedgehog induces the differentiation of ventral forebrain neurons: a common signal for ventral patterning within the neural tube. Cell 81: 747-756. doi: 10.1016/0092-8674(95)90536-7
    [27] Flandin P, Zhao Y, Vogt D, et al. (2001) Lhx6 and Lhx8 coordinately induce neuronal expression of Shh that controls the generation of interneuron progenitors. Neuron 70: 939-950.
    [28] Shimamura K, Hartigan DJ, Martinez S, et al. (1995) Longitudinal organization of the anterior neural plate and neural tube. Development 121: 3923-3933.
    [29] Sussel L, Marin O, Kimura S, et al. (1999) Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon: evidence for a transformation of the pallidum into the striatum. Development 126: 3359-3370.
    [30] Fuccillo M, Rallu M, McMahon AP, et al. (2004) Temporal requirement for hedgehog signaling in ventral telencephalic patterning. Development 131: 5031-5040. doi: 10.1242/dev.01349
    [31] Wonders CP, Taylor L, Welagen J, et al. (2008) A spatial bias for the origins of interneuron subgroups within the medial ganglionic eminence. Dev Biol 314: 127-136. doi: 10.1016/j.ydbio.2007.11.018
    [32] Xu Q, Cobos I, Cruz EDL, et al. (2004) Origins of cortical interneuron subtypes. J Neurosci 24: 2612-2622. doi: 10.1523/JNEUROSCI.5667-03.2004
    [33] Xu Q, Wonders CP, Anderson SA (2005) Sonic hedgehog maintains the identity of cortical interneuron progenitors in the ventral telencephalon. Development 132: 4987-4998. doi: 10.1242/dev.02090
    [34] Xu Q, Guo L, Moore H, et al. (2010) Sonic hedgehog signaling confers ventral telencephalic progenitors with distinct cortical interneuron fates. Neuron 65: 328-340. doi: 10.1016/j.neuron.2010.01.004
    [35] Gulacsi A, Anderson SA (2006) Shh maintains Nkx2.1 in the MGE by a Gli3-independent mechanism. Cereb Cortex 16: i89-95.
    [36] Batista-Brito R, Rossignol E, Hjerling-Leffler J, et al. (2009) The cell-intrinsic requirement of Sox6 for cortical interneuron development. Neuron 63: 466-481. doi: 10.1016/j.neuron.2009.08.005
    [37] Lei Q, Jeong Y, Misra K, et al. (2006) Wnt signaling inhibitors regulate the transcriptional response to morphogenetic Shh-Gli signaling in the neural tube. Dev Cel 11: 325-337. doi: 10.1016/j.devcel.2006.06.013
    [38] Aoto K, Nishimura T, Eto K, et al. (2002) Mouse GLI3 regulates Fgf8 expression and apoptosis in the developing neural tube, face, and limb bud. Dev Biol 251: 320-332. doi: 10.1006/dbio.2002.0811
    [39] Gulacsi A, Lillien L (2003) Sonic hedgehog and bone morphogenetic protein regulate interneuron development from dorsal telencephalic progenitors in vitro. J Neurosci 23:
    9862-9872.
    [40] Anderson RM, Lawrence AR, Stottmann RW, et al. (2002) Chordin and noggin promote organizing centers of forebrain development in the mouse. Development 129: 4975-4987.
    [41] Mukhopadhyay A, McGuire T, Peng CY, et al. (2009) Differential effects of BMP signaling on parvalbumin and somatostatin interneuron differentiation. Development 136: 2633-2642. doi: 10.1242/dev.034439
    [42] Samanta J, Burke GM, McGuire T, et al. (2007) BMPR1a signaling determines numbers of oligodendrocytes and calbindin-expressing interneurons in the cortex. J Neurosci 27: 7397-7407. doi: 10.1523/JNEUROSCI.1434-07.2007
    [43] Wine-Lee L, Ahn KJ, Richardson RD, et al. (2004) Signaling through BMP type 1 receptors is required for development of interneuron cell types in the dorsal spinal cord. Development 131: 5393-5403. doi: 10.1242/dev.01379
    [44] Gutin G, Marie F, Laura P, et al. (2006) FGF signalling generates ventral telencephalic cells independently of SHH. Development 133: 2937-2946. doi: 10.1242/dev.02465
    [45] Ohkubo Y, Chiang C, Rubenstein JL (2002) Coordinate regulation and synergistic actions of BMP4, SHH and FGF8 in the rostral prosencephalon regulate morphogenesis of the telencephalic and optic vesicles. Neuroscience 111: 1-17. doi: 10.1016/S0306-4522(01)00616-9
    [46] Machon O, van den Bout CJ, Backman M, et al. (2003) Role of beta-catenin in the developing cortical and hippocampal neuroepithelium. Neuroscience 122: 129-143. doi: 10.1016/S0306-4522(03)00519-0
    [47] Woodhead GJ, Mutch CA, Olson EC, et al. (2006) Cell-autonomous beta-catenin signaling regulates cortical precursor proliferation. J Neurosci 26: 12620-12630. doi: 10.1523/JNEUROSCI.3180-06.2006
    [48] Zhou CJ, Borello U, Rubenstein JL, et al. (2006) Neuronal production and precursor proliferation defects in the neocortex of mice with loss of function in the canonical Wnt signaling pathway. Neuroscience 142: 1119-1131.
    [49] Zhou CJ, Zhao C, Pleasure SJ (2004) Wnt signaling mutants have decreased dentate granule cell production and radial glial scaffolding abnormalities. J Neurosci 24: 121-126. doi: 10.1523/JNEUROSCI.4071-03.2004
    [50] Backman M, Machon O, Mygland L, et al. (2005) Effects of canonical Wnt signaling on dorso-ventral specification of the mouse telencephalon. Dev Biol 279: 155-168. doi: 10.1016/j.ydbio.2004.12.010
    [51] Gulacsi AA, Anderson SA (2008) Beta-catenin-mediated Wnt signaling regulates neurogenesis in the ventral telencephalon. Nat Neurosci 11: 1383-1391. doi: 10.1038/nn.2226
    [52] Martinez-Morales PL, Quiroga AC, Barbas JA, et al. (2010) SOX5 controls cell cycle progression in neural progenitors by interfering with the WNT-beta-catenin pathway. EMBO Rep 11: 466-472. doi: 10.1038/embor.2010.61
    [53] Pino D, Choe Y, Pleasure SJ (2011) Wnt5a controls neurite development in olfactory bulb interneurons. ASN Neuro 3: e00059.
    [54] Vidaki M, Tivodar S, Doulgeraki K, et al. (2012) Rac1-dependent cell cycle exit of MGE precursors and GABAergic interneuron migration to the cortex. Cereb Cortex 22: 680-692. doi: 10.1093/cercor/bhr145
    [55] Marin O, Yaron A, Bagri A, et al. (2001) Sorting of striatal and cortical interneurons regulated by semaphorin-neuropilin interactions. Science 293: 872-875. doi: 10.1126/science.1061891
    [56] Marin O, Anderson SA, Rubenstein JL (2000) Origin and molecular specification of striatal interneurons. J Neurosci 20: 6063-6076.
    [57] Lumb R, Wiszniak S, Kabbara S, et al. (2014) Neuropilins define distinct populations of neural crest cells. Neural Dev 9: 24. doi: 10.1186/1749-8104-9-24
    [58] Schwarz Q, Maden CH, Vieira JM, et al. (2009) Neuropilin 1 signaling guides neural crest cells to coordinate pathway choice with cell specification. Proc Natl Acad Sci U S A 106: 6164-6169. doi: 10.1073/pnas.0811521106
    [59] Schwarz Q, Ruhrberg C (2010) Neuropilin, you gotta let me know: Should I stay or should I go? Cell Adh Migr 4.
    [60] Hernandez-Miranda LR., Anna C, Clare F, et al. (2011) Robo1 regulates semaphorin signaling to guide the migration of cortical interneurons through the ventral forebrain. J Neurosci 31: 6174-6187. doi: 10.1523/JNEUROSCI.5464-10.2011
    [61] Marin O, Baker J, Puelles L, et al. (2002) Patterning of the basal telencephalon and hypothalamus is essential for guidance of cortical projections. Development 129: 761-773.
    [62] Zimmer G, Rudolph J, Landmann J, et al. (2011) Bidirectional ephrinB3/EphA4 signaling mediates the segregation of medial ganglionic eminence- and preoptic area-derived interneurons in the deep and superficial migratory stream. J Neurosci 31: 18364-18380. doi: 10.1523/JNEUROSCI.4690-11.2011
    [63] Zimmer G, Garcez P, Rudolph J, et al. (2008) Ephrin-A5 acts as a repulsive cue for migrating cortical interneurons. Eur J Neurosci 28: 62-73. doi: 10.1111/j.1460-9568.2008.06320.x
    [64] Friocourt G, Parnavelas JG (2010) Mutations in ARX Result in Several Defects Involving GABAergic Neurons. Front Cell Neurosci 4: 4.
    [65] Flames N, Long JE, Garratt AN, et al. (2004) Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron 44: 251-261. doi: 10.1016/j.neuron.2004.09.028
    [66] Li H, Chou SJ, Hamasaki T, et al. (2012) Neuregulin repellent signaling via ErbB4 restricts GABAergic interneurons to migratory paths from ganglionic eminence to cortical destinations. Neural Dev 7: 10. doi: 10.1186/1749-8104-7-10
    [67] Balabanian K, Lagane B, Infantino S, et al. (2005) The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280: 35760-35766. doi: 10.1074/jbc.M508234200
    [68] Wang Y, Li G, Stanco A, et al. (2011) CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. Neuron 69: 61-76. doi: 10.1016/j.neuron.2010.12.005
    [69] Hevner RF, Daza RA, Englund C, et al. (2004) Postnatal shifts of interneuron position in the neocortex of normal and reeler mice: evidence for inward radial migration. Neuroscience 124: 605-618.
    [70] Nadarajah B, Alifragis P, Wong RO, et al. (2003) Neuronal migration in the developing cerebral cortex: observations based on real-time imaging. Cereb Cortex 13: 607-611. doi: 10.1093/cercor/13.6.607
    [71] Nadarajah B, Parnavelas JG (2002) Modes of neuronal migration in the developing cerebral cortex. Nat Rev Neurosci 3: 423-432. doi: 10.1038/nrn845
    [72] Polleux F, Whitford KL, Dijkhuizen PA, et al. (2002) Control of cortical interneuron migration by neurotrophins and PI3-kinase signaling. Development 129: 3147-3160.
    [73] Lysko DE, Putt M, Golden JA (2011) SDF1 regulates leading process branching and speed of migrating interneurons. J Neurosci 31: 1739-1745. doi: 10.1523/JNEUROSCI.3118-10.2011
    [74] Miyoshi G, Fishell G (2011) GABAergic interneuron lineages selectively sort into specific cortical layers during early postnatal development. Cereb Cortex 21: 845-852. doi: 10.1093/cercor/bhq155
    [75] Vogt D, Hunt RF, Mandal S, et al. (2014) Lhx6 directly regulates Arx and CXCR7 to determine cortical interneuron fate and laminar position. Neuron 82: 350-364. doi: 10.1016/j.neuron.2014.02.030
    [76] English JA, Dicker P, Föcking M, et al (2009) 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease. Proteomics 9: 3368-3382. doi: 10.1002/pmic.200900015
    [77] Insel TR (2010) Rethinking schizophrenia. Nature 468: 187-193. doi: 10.1038/nature09552
    [78] Walsh T, McClellan JM, McCarthy SE, et al. (2008) Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320: 539-543. doi: 10.1126/science.1155174
    [79] Lewis DA, Levitt P (2002) Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25: 409-432. doi: 10.1146/annurev.neuro.25.112701.142754
    [80] Benes FM, Vincent SL, Alsterberg G, et al. (1992) Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12: 924-929.
    [81] Konradi C, Yang CK, Zimmerman EI, et al. (2011) Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res 131: 165-173. doi: 10.1016/j.schres.2011.06.007
    [82] Wang AY, Lohmann KM, Yang CK, et al. (2011) Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region. Acta Neuropathol 122: 615-626. doi: 10.1007/s00401-011-0881-4
    [83] Joshi D, Fung SJ, Rothwell A, et al. (2012) Higher gamma-aminobutyric acid neuron density in the white matter of orbital frontal cortex in schizophrenia. Biol Psychiatry 72: 725-733. doi: 10.1016/j.biopsych.2012.06.021
    [84] Daviss SR, Lewis DA (1995) Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res 59: 81-96. doi: 10.1016/0165-1781(95)02720-3
    [85] Ikeda K, Ikeda K, Iritani S, et al. (2004) Distribution of neuropeptide Y interneurons in the dorsal prefrontal cortex of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28: 379-383. doi: 10.1016/j.pnpbp.2003.11.008
    [86] Morris HM, Hashimoto T, Lewis DA (2008) Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cereb Cortex 18: 1575-1587. doi: 10.1093/cercor/bhm186
    [87] Yang Y, Fung SJ, Rothwell A, et al. (2011) Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia. Biol Psychiatry 69: 63-70. doi: 10.1016/j.biopsych.2010.08.020
    [88] Di Rosa E, Crow TJ, Walker MA, et al. (2009) Reduced neuron density, enlarged minicolumn spacing and altered ageing effects in fusiform cortex in schizophrenia. Psychiatry Res 166:
    102-115.
    [89] Chance SA, Walker M, Crow TJ (2005) Reduced density of calbindin-immunoreactive interneurons in the planum temporale in schizophrenia. Brain Res 1046: 32-37. doi: 10.1016/j.brainres.2005.03.045
    [90] Akbarian S, Huang HS (2006) Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 52: 293-304. doi: 10.1016/j.brainresrev.2006.04.001
    [91] Akbarian S, Kim JJ, Potkin SG, et al. (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52: 258-266. doi: 10.1001/archpsyc.1995.03950160008002
    [92] Costa E, Davis JM, Dong E, et al. (2004) A GABAergic cortical deficit dominates schizophrenia pathophysiology. Crit Rev Neurobiol 16: 1-23.
    [93] Huang HS, Akbarian S (2007) GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS One 2: e809. doi: 10.1371/journal.pone.0000809
    [94] Impagnatiello F, Guidotti AR, Pesold C, et al. (1998) A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A 95: 15718-15723. doi: 10.1073/pnas.95.26.15718
    [95] Kalkman HO, Loetscher E (2003) GAD(67): the link between the GABA-deficit hypothesis and the dopaminergic- and glutamatergic theories of psychosis. J Neural Transm (Vienna) 110:
    803-812.
    [96] Knable MB, Barci BM, Bartko JJ, et al. (2002) Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers. Mol Psychiatry 7: 392-404. doi: 10.1038/sj.mp.4001034
    [97] Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6: 312-324. doi: 10.1038/nrn1648
    [98] Mirnics K, Middleton FA, Marquez A, et al. (2000) Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28: 53-67. doi: 10.1016/S0896-6273(00)00085-4
    [99] Thompson RM, Weickert CS, Wyatt E, et al. (2011) Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci 36: 195-203. doi: 10.1503/jpn.100048
    [100] Volk DW, Lewis DA (2002) Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol Behav 77: 501-505. doi: 10.1016/S0031-9384(02)00936-8
    [101] Hashimoto T, Arion D, Unger T, et al. (2008) Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 13: 147-161. doi: 10.1038/sj.mp.4002011
    [102] Hashimoto T, Bazmi HH, Mirnics K, et al. (2008) Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatr 165: 479-489. doi: 10.1176/appi.ajp.2007.07081223
    [103] Hoftman GD, Volk DW, Bazmi HH, et al. (2015) Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance. Schizophr Bull 41: 180-191. doi: 10.1093/schbul/sbt178
    [104] Maldonado-Aviles JG, Curley AA, Hashimoto T, et al. (2009) Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia. Am J Psychiatry 166: 450-459. doi: 10.1176/appi.ajp.2008.08101484
    [105] Chong VZ, Thompson M, Beltaifa S, et al. (2008) Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res 100: 270-280. doi: 10.1016/j.schres.2007.12.474
    [106] Harrison PJ, Law AJ (2006) Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 60: 132-140. doi: 10.1016/j.biopsych.2005.11.002
    [107] Hashimoto R, Straub RE, Weickert CS, et al. (2004) Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 9: 299-307. doi: 10.1038/sj.mp.4001434
    [108] Law AJ, Lipska BK, Weickert CS, et al. (2006) Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci U S A 103: 6747-6752. doi: 10.1073/pnas.0602002103
    [109] Iritani S, Kuroki N, Niizato K, et al. (2000) Morphological changes in neuropeptide Y-positive fiber in the hippocampal formation of schizophrenics. Prog Neuropsychopharmacol Biol Psychiatry 24: 241-249. doi: 10.1016/S0278-5846(99)00102-5
    [110] Kuromitsu J, Yokoi A, Kawai T, et al. (2001) Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder. Brain Res Gene Expr Patterns 1: 17-21. doi: 10.1016/S1567-133X(01)00003-5
    [111] Mellios N, Huang HS, Baker SP, et al. (2009) Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry 65: 1006-1014. doi: 10.1016/j.biopsych.2008.11.019
    [112] Volk DW, Matsubara T, Li S, et al. (2012) Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am J Psychiatry 169: 1082-1091. doi: 10.1176/appi.ajp.2012.12030305
    [113] Straub RE, Lipska BK, Egan MF, et al. (2007) Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry 12: 854-869. doi: 10.1038/sj.mp.4001988
    [114] Costa E, Grayson DR, Mitchell CP, et al. (2003) GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability. Crit Rev Neurobiol 15: 121-142. doi: 10.1615/CritRevNeurobiol.v15.i2.20
    [115] Grayson DR, Chen Y, Costa E, et al. (2006) The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Pharmacol Ther 111: 272-286. doi: 10.1016/j.pharmthera.2005.01.007
    [116] Grayson DR, Jia X, Chen Y, et al. (2005) Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A 102: 9341-9346. doi: 10.1073/pnas.0503736102
    [117] Tochigi M, Iwamoto K, Bundo M, et al. (2008) Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol Psychiatry 63: 530-533. doi: 10.1016/j.biopsych.2007.07.003
    [118] Veldic M, Caruncho HJ, Liu WS, et al. (2004) DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc Natl Acad Sci U S A 101: 348-353. doi: 10.1073/pnas.2637013100
    [119] Veldic M, Kadriu B, Maloku E, et al. (2007) Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res 91: 51-61. doi: 10.1016/j.schres.2006.11.029
    [120] Gorski JA, Caruncho HJ, Liu WS, et al. (2007) Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 23: 6856-6865.
    [121] Knusel B, Rabin SJ, Hefti F, et al. (1994) Regulated neurotrophin receptor responsiveness during neuronal migrationand early differentiation. J Neurosci 14: 1542-1554.
    [122] Egan MF, Kojima M, Callicott JH, et al. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269. doi: 10.1016/S0092-8674(03)00035-7
    [123] Gratacos M, González JR, Mercader JM, et al. (2007) Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 61: 911-922. doi: 10.1016/j.biopsych.2006.08.025
    [124] Fromer M, Pocklington AJ, Kavanagh DH, et al. (2014) De novo mutations in schizophrenia implicate synaptic networks. Nature 506: 179-184. doi: 10.1038/nature12929
    [125] Hosak L (2013) New findings in the genetics of schizophrenia. World J Psychiatry 3: 57-61. doi: 10.5498/wjp.v3.i3.57
    [126] Silberberg G, Darvasi A, Pinkas-Kramarski R, et al. (2006) The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B Neuropsychiatr Genet 141B: 142-148. doi: 10.1002/ajmg.b.30275
    [127] Belforte JE, Zsiros V, Sklar ER, et al. (2010) Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 13: 76-83. doi: 10.1038/nn.2447
    [128] Del Arco A, Segovia G, Mora F (2008) Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity. Psychopharmacology. 201: 325-338. doi: 10.1007/s00213-008-1288-3
    [129] Inan M, Petros TJ, Anderson SA (2013) Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia. Neurobiol Dis 53: 36-48. doi: 10.1016/j.nbd.2012.11.013
    [130] Chattopadhyaya B, Di Cristo G, Wu CZ, et al. (2007) GAD67-mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex. Neuron 54: 889-903. doi: 10.1016/j.neuron.2007.05.015
    [131] Schmidt MJ, Horvath S, Ebert P, et al. (2014) Modulation of behavioral networks by selective interneuronal inactivation. Mol Psychiatry 19: 580-587. doi: 10.1038/mp.2013.167
    [132] Kvitsiani D, Ranade S, Hangya B, et al. (2013) Distinct behavioural and network correlates of two interneuron types in prefrontal cortex. Nature 498: 363-366. doi: 10.1038/nature12176
    [133] Fisahn A, Neddens J, Yan L, et al. (2009) Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia. Cereb Cortex 19: 612-618. doi: 10.1093/cercor/bhn107
    [134] Del Pino I, García-Frigola C, Dehorter N, et al. (2013) Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron 79: 1152-1168. doi: 10.1016/j.neuron.2013.07.010
    [135] Millar JK, Christie S, Semple CA, et al. (2000) Chromosomal location and genomic structure of the human translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISC1, a gene disrupted by a translocation segregating with schizophrenia. Genomics 67: 69-77. doi: 10.1006/geno.2000.6239
    [136] Steinecke A, Gampe C, Valkova C, et al. (2012) Disrupted-in-Schizophrenia 1 (DISC1) is necessary for the correct migration of cortical interneurons. J Neurosci 32: 738-745. doi: 10.1523/JNEUROSCI.5036-11.2012
    [137] Matsumoto H, Higa HH (1966) Studies on methylazoxymethanol, the aglycone of cycasin: methylation of nucleic acids in vitro. Biochem J 98: 20C-22C. doi: 10.1042/bj0980020C
    [138] Lodge DJ, Behrens MM, Grace AA (2009) A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci 29: 2344-2354. doi: 10.1523/JNEUROSCI.5419-08.2009
    [139] Penschuck S, Flagstad P, Didriksen M, et al. (2006) Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia. Eur J Neurosci 23: 279-284. doi: 10.1111/j.1460-9568.2005.04536.x
    [140] Canetta SE, Brown AS (2012) Prenatal Infection, Maternal Immune Activation, and Risk for Schizophrenia. Transl Neurosci 3: 320-327.
    [141] Meyer U (2014) Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 75: 307-315. doi: 10.1016/j.biopsych.2013.07.011
    [142] Bitanihirwe BK, Peleg-Raibstein D, Mouttet F, et al. (2010) Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology 35: 2462-2478. doi: 10.1038/npp.2010.129
    [143] Deslauriers J, Larouche A, Sarret P, et al. (2013) Combination of prenatal immune challenge and restraint stress affects prepulse inhibition and dopaminergic/GABAergic markers. Prog Neuropsychopharmacol Biol Psychiatry 45: 156-164. doi: 10.1016/j.pnpbp.2013.05.006
    [144] Nyffeler M, Meyer U, Yee BK, et al. (2006) Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience 143: 51-62. doi: 10.1016/j.neuroscience.2006.07.029
    [145] Richetto J, Calabrese F, Meyer U, et al. (2013) Prenatal versus postnatal maternal factors in the development of infection-induced working memory impairments in mice. Brain Behav Immun 33: 190-200. doi: 10.1016/j.bbi.2013.07.006
    [146] Abazyan B, Nomura J, Kannan G, et al. (2010) Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry 68: 1172-1181. doi: 10.1016/j.biopsych.2010.09.022
    [147] Lipina TV, Niwa M, Jaaro-Peled H, et al. (2010) Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. Genes Brain Behav 9: 777-789. doi: 10.1111/j.1601-183X.2010.00615.x
    [148] Jones CA, Watson DJ, Fone KC (2011) Animal models of schizophrenia. Br J Pharmacol 164: 1162-1194. doi: 10.1111/j.1476-5381.2011.01386.x
    [149] Bloomfield C, French SJ, Jones DN, et al. (2008) Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats. Synapse 62: 628-631. doi: 10.1002/syn.20521
    [150] Harte MK, Powell SB, Swerdlow NR, et al. (2007) Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats. J Neural Transm (Vienna) 114: 893-898. doi: 10.1007/s00702-007-0627-6
    [151] Cassidy AW, Mulvany SK, Pangalos MN, et al. (2010) Developmental emergence of reelin deficits in the prefrontal cortex of Wistar rats reared in social isolation. Neuroscience 166: 377-385. doi: 10.1016/j.neuroscience.2009.12.045
    [152] Giovanoli S, Engler H, Engler A, et al. (2013) Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 339: 1095-1099. doi: 10.1126/science.1228261
    [153] Agim ZS, Esendal M, Briollais L, et al. (2013) Discovery, validation and characterization of Erbb4 and Nrg1 haplotypes using data from three genome-wide association studies of schizophrenia. PLoS One 8: e53042. doi: 10.1371/journal.pone.0053042
    [154] Lu CL, Wang YC, Chen JY, et al. (2010) Support for the involvement of the ERBB4 gene in schizophrenia: a genetic association analysis. Neurosci Lett 481: 120-125. doi: 10.1016/j.neulet.2010.06.067
    [155] Shi J, Levinson DF, Duan J, et al. (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757.
    [156] Kimura S, Hara Y, Pineau T, et al. (1996) The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 10: 60-69. doi: 10.1101/gad.10.1.60
    [157] Chiang C, Litingtung Y, Lee E, et al. (1996) Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 383: 407-413. doi: 10.1038/383407a0
    [158] Hafner H, Maurer K, Löffler W, et al. (1994) The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. Br J Psychiatry Suppl: 29-38.
    [159] Crews F, He J, Hodge C (2007) Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav 86: 189-199. doi: 10.1016/j.pbb.2006.12.001
    [160] Spear LP (2000) The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24: 417-463. doi: 10.1016/S0149-7634(00)00014-2
    [161] Andersen SL, Teicher MH (2008) Stress, sensitive periods and maturational events in adolescent depression. Trends Neurosci 31: 183-191. doi: 10.1016/j.tins.2008.01.004
    [162] Andersen SL, Thompson AT, Rutstein M, et al. (2000) Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse 37: 167-169.
    [163] Fiorentini A, Rosi MC, Grossi C, et al. (2010) Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mutant mice. PLoS One 5: e14382. doi: 10.1371/journal.pone.0014382
    [164] Wang JM, Singh C, Liu L, et al. (2010) Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 107: 6498-6503. doi: 10.1073/pnas.1001422107
    [165] Guidotti A, Auta J, Davis JM, et al. (2014) Toward the identification of peripheral epigenetic biomarkers of schizophrenia. J Neurogenet 28: 41-52. doi: 10.3109/01677063.2014.892485
    [166] Wichterle H, Garcia-Verdugo JM, Herrera DG, et al. (1999) Young neurons from medial ganglionic eminence disperse in adult and embryonic brain. Nat Neurosci 2: 461-466. doi: 10.1038/8131
    [167] Perez SM, Lodge DJ (2013) Hippocampal interneuron transplants reverse aberrant dopamine system function and behavior in a rodent model of schizophrenia. Mol Psychiatry 18: 1193-1198. doi: 10.1038/mp.2013.111
    [168] Tyson JA, Anderson SA (2014) GABAergic interneuron transplants to study development and treat disease. Trends Neurosci 37: 169-177. doi: 10.1016/j.tins.2014.01.003
  • This article has been cited by:

    1. Maya R. Davies, Zarina Greenberg, Dannis G. van Vuurden, Courtney B. Cross, Andrew C.W. Zannettino, Cedric Bardy, Hannah R. Wardill, More than a small adult brain: Lessons from chemotherapy-induced cognitive impairment for modelling paediatric brain disorders, 2024, 115, 08891591, 229, 10.1016/j.bbi.2023.10.013
  • Reader Comments
  • © 2015 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(9477) PDF downloads(1363) Cited by(1)

Article outline

Figures and Tables

Figures(3)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog